Merge Gains Visibility on RW Baird Comments

Comments from RW Baird Friday morning point to Merge Healthcare (NASDAQ:MRGE) as a strong stock with near-term value drivers and potential as a take-out candidate. Merge is a medical IT company that is set to climb higher in the second half of the year after changing its business model drastically, from up-front licensing to subscription-based sales. See our report on Merge from earlier this week to read more about why this company has potential to double into 2013.